Q2 2026 Holdings
Filed 2026-08-13 | 13 holdings | $307.8M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Vaxcyte Inc(PCVX) | COM | 92243G108 | $82.9M | 1,425,470 | 26.9% |
| Arcutis Biotherapeutics Inc(ARQT) | COM | 03969K108 | $33.2M | 1,265,283 | 10.8% |
| Trevi Therapeutics Inc(TRVI) | COM | 89532M101 | $32.5M | 1,742,672 | 10.6% |
| Avalyn Pharmaceuticals Inc(AVLN) | COM SHS | 05348Y105 | $31.8M | 966,792 | 10.3% |
| Evommune Inc(EVMN) | COM SHS | 30054Y107 | $25.6M | 1,926,943 | 8.3% |
| Maplight Therapeutics Inc(MPLT) | COM | 56565P103 | $21.9M | 611,446 | 7.1% |
| Oculis Holding AG(OCS) | ORDINARY SHARES | H5870P102 | $20.9M | 1,506,250 | 6.8% |
| Bioage Labs Inc(BIOA) | COM | 09077V100 | $16.0M | 653,374 | 5.2% |
| Immunome Inc(IMNM) | COM | 45257U108 | $15.5M | 732,512 | 5.0% |
| Zenas Biopharma Inc(ZBIO) | COM | 98937L105 | $12.5M | 490,766 | 4.0% |
| Avalo Therapeutics Inc(AVTX) | COM NEW | 05338F306 | $8.0M | 434,033 | 2.6% |
| Rallybio Corp(RLYB) | COM | 75120L209 | $4.8M | 300,579 | 1.6% |
| Recursion Pharmaceuticals in(RXRX) | CL A | 75629V104 | $2.2M | 595,518 | 0.7% |